ARMSTRONG ADVISORY GROUP, INC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1932952
NEEDHAM, MA
Position in HALO
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$19,389
-$801 QoQ
Shares Held
300
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARMSTRONG ADVISORY GROUP, INC holds $191,083 across 11 Biotechnology names. HALO ranks #3 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
423 | $71,495 | |
| 2 | VANI |
Vivani Medical, Inc.
|
65,000 | $65,000 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
This page
|
300 | $19,389 | |
| 4 | MRNA |
Moderna, Inc.
|
263 | $13,360 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
272 | $10,469 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
52 | $5,057 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6 | $4,635 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
31 | $1,474 |
All Filings in HALO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,389 | 300 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $20,190 | 300 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $22,002 | 300 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $15,606 | 300 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $6,381 | 100 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $4,781 | 100 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $5,724 | 100 | Shares | Sole | 2024-10-11 | |
| No filing history on record for this holder in this stock. | ||||||